BioMed Israel 2006 Exhibitor Profiles.

JERUSALEM -- BioMed Israel 2006 takes place May 29 - 31, 2006 at the ICC Jerusalem International Convention Center. For in-depth information about the event visit http://www.kenes.com/biomed/. Below are profiles from BioMed Israel 2006 exhibitors.

Business Wire is the official news wire for BioMed Israel 2006. Breaking news releases and photos are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.

Company:  Adam Sharon Management Ltd.
Booth/Stand: 131
Investor Relations Contact: Nathan Sharon
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.adamsharon.co.il

Adam Sharon Management Ltd. established in 1995 by Nathan Sharon. Our
expertise is Human Resource consultant and management in the
Biosciences industry. Adam Sharon Management Ltd. offers a range of
services:

- A quality human resource placement in the Bioscience industry.
- Compensation and benefit systems.
- Long-term retention plans.
- Employee incentive systems.
- Establishing human resources database.
- Human resources evaluation systems.
- Human resources training and development programs.
- Compensation and benefit benchmark surveys.
- Out placement services
- Merger and Acquisition support.

Company:   A.D. Cleanrooms Engineering (2005) Ltd.
Booth/Stand:  109
Media Contact:     Gil Shapira
Phone:    (office) [phone]
E-mail:   [e-mail]
Web:      www.cleanrooms.co.il

A.D. Cleanrooms Engineering Ltd. is a complete turnkey provider of
cleanrooms - from envelope to entire mechanical systems. We design,
manufacture and build for the pharmaceutical, biotechnology, medical
devices and semiconductor industries. A.D. Cleanrooms is part of U.
Dori Group, one of Israel's leading construction companies. Our
customers include: Teva, Taro, Agis, Phillips, CME, Superdimension,
PCB, Microswiss among others. We are the exclusive importers of Delta
2000 (Italy) and Dagard (France) A.D. Cleanrooms Engineering Ltd. is
ISO 9001:2000 and IQNet certified for design and construction of
cleanrooms and mechanical systems.

Company:  Biological Industries
Booth/Stand:     115
Media Contact:   Gary Bennett
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.bioind.com

Biological Industries (established in 1981) is a manufacturer of
products for animal cell culture and molecular biology, with exports
via distributors to 30 countries. Among our customers are research
institutes and biotech manufacturers. In addition, we have a highly
successful product line for cytogenetics (diagnostics) laboratories.
All manufacturing is conducted in a fully cGMP facility. The company
also serves as the exclusive distributor in Israel for 18 foreign
manufacturers, primarily in the areas of molecular biology and
filtration technology.

Company:  BioSante Pharmaceuticals, Inc.
Ticker Symbol & Exchange:     BPA --Amex
Media Contact:      Stephen M. Simes
Investor Relations Contact:   Phillip Donenberg
Phone:    [phone] ext 100
E-mail:   [e-mail]
Web:      www.biosantepharma.com

BioSante is developing a pipeline of hormone therapy products to
treat both men and women. These hormone therapy products are gel
formulations for transdermal administration that deliver bioidentical
estradiol and testosterone. BioSante's lead products include
Bio-E-Gel(TM) (transdermal estradiol gel) for the treatment of women
with menopausal symptoms, and LibiGel(TM) (transdermal testosterone
gel) for the treatment of female sexual dysfunction (FSD). A Bio-E-Gel
new drug application (NDA) was submitted to the FDA on February 16,
2006. The current market in the U.S. for estrogen and testosterone
products is approximately $2.5 billion. The company also is developing
its calcium phosphate nanotechnology (CaP) for novel vaccines,
including biodefense vaccines for toxins such as anthrax and ricin,
and drug delivery systems.

Company:  Do-Coop Technologies Ltd.
Booth/Stand:     10
Media Contact:   Miguel Cizin
Investor Relations Contact:   Eran Gabbai
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.docoop.com

Neowater(TM) is an enabling technology that is based on breakthrough
water-based nanotechnology. Unlike traditional, dry nanotechnology,
which focuses on a nanoparticle end product, Neowater(TM) builds upon
the unique properties of nanoparticles to modify the physical
properties of water molecules around them. Neowater, a novel
proprietary water-based nanotechnology, is a broad enabling platform
upon which research, diagnostics, biotech and pharma companies can
obtain disruptive price-performance results with a simple, graceful
implementation. Neowater(TM)-based products also significantly
accelerate and improve the efficiency of biological reactions.

Company:  Dr. Eyal Bressler & Co.
Booth/Stand:     139
Media Contact:   Dr. Eyal Bressler
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.bressler.co.il

Dr. Eyal Bressler & Co. is an Israeli boutique Intellectual Property
firm, active in a wide range of technological and scientific fields.
Patent Attorney Dr. Eyal Bressler, previously the CEO of a Venture
Capital fund, is the recipient of respected academic awards and has
published papers in the fields of biotechnology, applied chemistry,
separation sciences and finance. The firm's staff are scientists,
engineers, and lawyers with advanced degrees in science and
technology, who specialize in the development of high quality IP
prosecution strategies, maximizing the benefits of new technologies
and securing wide and cost-effective protection for clients'
inventions.


Company:  Dr. Reddy's Laboratories Limited
Booth/Stand:     108, Pinkus Hall
Ticker Symbol & Exchange:     NYSE:RDY
Media Contact:      Mr. Satish Mahanti
Investor Relations Contact:   Mr. Nikhil Shah
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.drreddys.com

Custom Pharmaceutical Services (CPS) division of Dr. Reddy's
Laboratories, with world-class pharmaceutical development &
manufacturing assets based in India, is a rapidly growing provider of
customized solutions to established and emerging pharmaceutical
companies worldwide. Our main focus is on development and
manufacturing of high quality pharmaceutical products cost-effectively
and on schedule. CPS's competitive advantage lies in its speed,
quality & cost-effectiveness. Our services include... 1) Process
Feasibility & Optimization 2) Scale-up and clinical supplies of NCE
APIs & Intermediates 3) Development of High potency APIs including
Cytotoxic & Hormonal APIs 4) Commercial supplies of APIs &
Intermediates 5) Formulations Research & Development 6) Dosage
Supplies for clinical studies 7) Contract Manufacturing of Dosage
Products

Company:  Evergreen Venture Partners
Media Contact:    Natalie Refuah; [e-mail]
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.evergreen.co.il

Evergreen Venture Partners was established in 1987 as one of Israel's
first venture capital firms and has grown into a market leader,
generating consistent top-quartile performances. Evergreen's $430
million of venture capital funds under management, invested in more
than 100 technology companies, represent one of the largest and most
successful portfolios in Israel. Evergreen invests in early-stage
Israeli and Israel-related companies in three main fields: software,
communications and healthcare. Our investments are positioned in
different segments of each of these markets, so that our investors can
benefit from a diversified and balanced portfolio of companies.
Evergreen has exited successfully 30 portfolio companies through IPOs
and acquisitions. Some of these companies include P-Cube, Actona,
Exalink, Creo, Galileo, Backweb, Radvision and Radware.

Company:  Experimental Pathology Laboratories, Inc
Booth/Stand:      26
Media Contact:    Dr. Jerry Hardisty
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.epl-inc.com

Experimental Pathology Laboratories (EPL(R)) provides contract
histology and toxicologic pathology support in two laboratories in the
United States near Washington, DC, and in North Carolina. Our
pathology services are provided by 25 experienced veterinary
pathologists, most certified by the American College of Veterinary
Pathologists. Technical and clerical staffs trained in reporting
pathology data support these pathologists. EPL's histology
laboratories are staffed by highly qualified technicians, including
certified Histologic Technicians. Our laboratories produce microscope
slides from more than 50,000 tissues per month. Among other services
offered are immunohistochemistry and digital morphometry. EPL operates
in full compliance with U.S. and International GLPs.

Company:  Global Translations
Booth/Stand:      110
Media Contact:    David Grunwald
Phone:    [phone]
E-mail:   [e-mail]
Web:      http://www.gts-translation.com

Global Translations provides a wide range of translation and
localization services for the Life Sciences industries. We support all
European directive languages and many Asian languages including
French, Italian, German, Spanish, Japanese, Russian, Chinese, Dutch,
Swedish and over 50 other languages. We have offices in the US,
Germany, England and Israel. Clients include leading companies in the
pharmaceutical, biotech and medical devices industries, and leading
Clinical Research Organizations (CROs). We provide expert translation
of Informed Consent Forms (ICF), Case Report Forms (CRF), clinical
protocols, patents, legal and regulatory documents. We provide
localization of medical software products and Internet websites.

Company:  Mandarin medical
Booth/Stand:  15
Media Contact:  Ido Berger
Phone:  [phone]
E-mail:    [e-mail]
Web:  www.mandarin-medical.com

Mandarin-Medical is a business development company who specializes in
the Healthcare business: Medical devices, Pharmaceuticals and
Bio-Technology.

Mandarin-Medical actively assists both Manufactures of innovative
healthcare products and Distributors in the Asia region in planning
and in action during the first 3-5 years of activity until the
business reaches a steady and a mature state. We operate through our
local offices spread in 5 major locations in the Asia Pacific rim.

Based on this strategy, we support companies in bringing in investors
from around the world and in finding suitable manufactures in Korea
and China.

Company:  Mattson Jack Group
Media Contact:   Dr. Shlomi Gilboa, M.D., M.P.H.
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.mattsonjack.com

Founded in 1986, Mattson Jack focuses its talent in three areas of
core competency: Business Analytics, Brand Optimization and Corporate
Development Services in the pharmaceutical and biotech markets.
Mattson Jack's ongoing mission is to "Accelerate Client Growth through
advanced analysis, planning, decision support and implementation.
Mattson Jack's global pharma and biotech expertise provides custom
epidemiology, technology assessment, primary market research, market
modeling and forecasting, pricing and reimbursement, business and
strategic plan development, due-diligence and licensing support.

Company:  Neopharm Cure Medical
Booth/Stand:     141
Media Contact:   Amir London
Phone:    + 972 4 6121212
E-mail:   [e-mail]
Web:      www.cure-mfg.co.il

Cure Medical Manufacturing, a division of the Neopharm Group a
leading Israeli-based Health Care Organization, is engaged in three
main businesses:

-- Large and Small Volume Parenterals and Hemodialysis solutions

-- cGMP/GLP sterile and non-sterile contract manufacturing,
pharmaceutical preparations, and testing services, servicing medical
device, pharmaceutical and biotech organizations.

-- WFI or RO Water-based formulations provided in bulk containers
or in single use disposable sterile bags.

Cure Manufacturing's facility and processes are fully cGMP compliant,
allowing the company to offer its clients an integrated, flexible
solution in the areas of manufacturing, sterilization, packaging, and
pharmaceutical preparations. Our services include QC testing, QA and
logistical support, and range from small-scale clinical supply to
long-term product manufacturing in dedicated suites.

Company:  Net-Translators Ltd.
Booth/Stand:     20
Media Contact:   Shy Avni
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.net-translators.com

Net-Translators Ltd. (www.net-translators.com) is a leading provider
of Translation and Localization services into over 40 languages. We
specialize in regulated industries such as medical devices, biotech,
pharmaceuticals, in vitro diagnostics, as well as Patent translations.

Company:  OrthoMediTec Ltd.
Booth/Stand:      133
Media Contact:    Ronen Shoushan,CEO
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.orthomeditec.com

OrthoMediTec Ltd. is a medical device start-up company specializing in
the field of orthopedic trauma solutions. OrthoMediTec will provide
surgeons with innovative, minimally invasive devices for the treatment
of patients in orthopedictrauma care. Trauma products are devices used
primarily to re-attach or stabilize damaged bone or tissue in order to
support the body's natural healing process. OrthoMediTec's first
product, the novel WaisFix(TM), is a groundbreaking solution for the
treatment of Proximal Femoral Fracture, a major market within trauma
care. The WaisFix(TM) is an innovative device for minimally invasive
hip fracture procedures that combines a new and unique internal nail
cage and an external adjustable fixator. The product is in the stage
of Beta batch production, mechanical and clinical tests. Intellectual
property rights are protected by patent registered in the USA, Europe
and Asia.

Company:  PharmaSeed
Booth/Stand:        140
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.pharmaseedltd.com

PharmaSeed Bioservices, a division of PharmaSeed Ltd., is an
innovative research-based biopharmaceutical company focused on drug
discovery in the early development phases. PharmaSeed Bioservices
provides preclinical and consulting services for medical device,
biotechnology and pharmaceutical companies who are interested in
outsourcing their research and development projects. Our integrated
and technically-driven approach and modern laboratories provides
affordable solutions to preclinical needs and for developing new
experimental models in a wide variety of areas, especially in our
particular fields of expertise - cancer, central nervous system, CNS
functional genomic and metabolic disorders. PharmaSeed Bioservices
guarantees a high level of technical expertise, absolute reliability,
efficient methodology, savings in costs and time, flexibility and
partnering opportunities

Company:  Pharmos Ltd.
Booth/Stand:        14
Ticker Symbol & Exchange:  pars
Media Contact:      Mr. Alon Michal
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.pharmoscorp.com

Pharmos discovers and develops novel immunomodulatory and
anti-inflammatory therapeutics to treat a range of disorders of the
central and peripheral nervous systems representing large potential
markets. These include neuropathic pain, post-surgical pain and a
range of autoimmune diseases such as multiple sclerosis, rheumatoid
arthritis, and inflammatory bowel disease. The Company's core
proprietary technology platform focuses on discovery and development
of synthetic cannabinoid compounds. Cannabinor (formerly PRS-211,375),
the lead CB2-selective receptor agonist candidate, is scheduled for
Phase II testing in pain indications during 2006. Cannabinor and other
compounds from this technology platform have demonstrated efficacy in
a number of animal models for neuropathic, inflammatory and noxious
pain, as well as animal models for RA MS and other disorders.

Company:  QuantomiX
Booth/Stand:     29
Media Contact:   Raffi Werner; [e-mail]
Investor Relations Contact:   Ory Zik; [e-mail]
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.quantomix.com

QuantomiX develops and markets breakthrough solutions based on its
proprietary WETSEM(TM) Technology, enabling imaging and analysis of
cells and tissues in their native environment. QuantomiX is now
offering LipidSCAN(TM) - a new Lipid Imaging Service, delivering
high-resolution visualization and quantification of lipids in cells
and tissues. QuantomiX laboratories and expert researchers are
providing comprehensive and reliable images and data revealing
intracellular localization and accurate quantification of lipid
accumulation. LipidSCAN(TM) answers the growing need for efficient
detection of lipid accumulation in early evaluation of drugs for
metabolic diseases. Ongoing developments include non-invasive
diagnostic applications, based on lipid quantification in white blood
cells.

Company:  Ramot at Tel Aviv University Ltd.
Booth/Stand:     05
Media Contact:   Ruth Ran
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.ramot.org

Ramot is the technology transfer company of Tel Aviv University (TAU),
Israel's largest university and an institution renowned for its
scientific departments and research productivity. Ramot's mission is
to transform TAU laboratory breakthroughs into high value commercial
technology. To that end Ramot enhances the commercial potential of
technologies developed at TAU by raising funding directed towards
applied research, and then transfers these technologies to the
industry through licensing and other commercial agreements. The Ramot
Life-Sciences team partners with corporations, venture partners, and
entrepreneurs. Current business partners include: Teva, Wyeth, Elan,
Agis, Taro, Aventis, Johnson & Johnson, Tubilux, Qbi, BiolineRx,
Predix and others.

Company:  Reinhold Cohn Group
Booth/Stand:      21
Media Contact:    Tamar Genosar
Investor Relations Contact:   Dr. Bossmat Gonen
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.rcip.co.il

The Reinhold Cohn Group is a full-service intellectual property firm.
Our expertise lies in the procurement, protection, enforcement,
litigation and licensing of patent, trademark, design, copyright, and
plant breeders' rights. The Reinhold Cohn Group is comprised of
Reinhold Cohn & Partners, Patent Attorneys, and Gilat, Bareket & Co.,
Attorneys at Law. Our teams of professionals have hand on experience
in many scientific and technological fields, including biotechnology,
chemistry, pharmaceuticals, medical devices, software and
computer-related technology, electrical and electronic engineering,
mechanical engineering and energy solutions. With our established
expertise we guide both small inventors and large concerns to promote
their vision with confidence.

Company:  Sunrise Projects
Booth/Stand:     138
Media Contact:   Nirit Olami-Hahn, Bashan PR
Phone:    [phone]
E-mail:   [e-mail]
Web:      www.sunrise.co.il

Sunrise Projects is a veteran R&D granting consultancy, specializing
in helping innovative Israeli companies maximize their R&D grants from
the NIH, the Israeli Office of the Chief Scientist, and the
Bi-National Funds (BIRDf, Eureka).

Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content to experts, company profiles, email alerts, survey services and other media services.

Note to Event Organizers: Add your trade show, conference, or event to www.tradeshownews.com, Business Wire's online event calendar. For information, email [e-mail].